Biologics & targeted DMARD therapeutics Flashcards
What monitoring should be done when on Biologics?
- For co-morbidities
- Full blood count (FBC)
- Renal function (eGFR, Cr)
- Liver function tests (LFT’s, esp. AST and ALT and also albumin)
- Test for tuberculosis
- Hepatitis screen (B and C)
- Chest x-ray
- Ongoing therapy should be reviewed at least every 6 months
What are you at risk of when taking biologics?
- Increased risk of Infection
Considerations required around surgery - Potential increased risk of malignancy
- Potential increased risk to patients with cardiac failure (class III or IV)
TNF inhibitors
T/F = Alcohol use is not ok with Biologics?
- No problems within normal limits (however may need reduction/cessation due to
concomitant DMARDs)
What pharmaceutical care issues are required for Biologics?
- Patients should remain on their specified brand of treatment unless it is converted under the direction of the prescriber
- Traceability – essential for pharmacovigilance
- Monitoring - specific
What class of drug is Infliximab and what preparations does it come as?
- Indications = RA
Preparations (originator drug and biosimilar agents). Powder for infusion (IV) AND Pre-filled pen (SC)
- Dosing: Example: RA (with MTX once a week) 3mg.kg at week 0, 2, 6 and then every 8 weeks
What is the treatment time with Infliximab?
IV infusion administration
- Over 2 hours and require 1 – 2 hours observations afterwards
- Pre-treatment – antihistamine, hydrocortisone and/or paracetamol
- The infusion rate may be lowered esp. if previous reactions
What are side-effects of Infliximab?
Very common – infection (upper respiratory infection), headache, infusion
related reaction, pain
Most serious – serious infections and reactivations, new or worsening HF,
delayed hypersensitivity, haematological reactions, demyelinating
disorders, hepatobiliary events, malignancies, serious infusion reactions
What are the contraindications of Infliximab?
- Hypersensitivity to other murine proteins
- Severe infection, TB, abscesses, opportunistic infections
- Moderate to severe heart failure
What are the cautions of Infliximab?
- Chronic/Hx recurrent infection/immunosuppressive drugs
- Patients with demyelinating diseases
- Malignancy
- Mild heart failure
- Elderly